New Insights into Suicide and Mental Health Conditions
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 64
Special Issue Editors
Interests: treatment-resistant depression; suicidality; suicidal ideation; clinical trials; neurophysiology; novel interventions; brain stimulation; magnetic seizure therapy; repetitive transcranial magnetic stimulation; psychedelics; psilocybin
Special Issue Information
Dear Colleagues,
Suicide is the most severe outcome for patients under psychiatric care. The rate of suicide is increasing in the US and in other developed countries. The vast majority of individuals who die by suicide suffer from co-morbid psychiatric illnesses, and many had contact with providers prior to their deaths. Interventions to reduce suicidal ideation and prevent suicide are limited. Therefore, there is an urgent need for researchers to develop effective and pragmatic interventions to target the growing suicide epidemic.
The goal of this Special Issue is to focus on research into novel interventions to reduce suicidal ideation, suicidal behavior, and suicide completions. The emphasis in this Special Issue will be on novel brain-based interventions that are tied to the underlying neurobiology or neurophysiology of pathological brain processes in suicide. In this issue, we also invite authors to explore novel clinical trial methodologies that may be employed in this population.
Through the advancement of our knowledge of new interventions to prevent suicide and novel methods of assessing this condition, we hope to progress this field and improve our ability to treat this devastating condition.
Dr. Cory R. Weissman
Dr. Zafiris Jeff Daskalakis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- suicide prevention
- clinical trial design
- pharmacological interventions
- brain stimulation
- novel interventions
